✦ LIBER ✦

Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab

✍ Scribed by Luc Darnige; Régis Peffault de Latour; Laurence Zemori; Gérard Socié; Anne-Marie Fischer; Dominique Helley; on behalf of the French Society of Haematology

Book ID: 108677247
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 114 KB
Volume: 153
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08665.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eculizumab, a terminal complement inhibi

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria

✍ Jörg Schubert; Peter Hillmen; Alexander Röth; Neal S. Young; Modupe O. Elebute; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Cardiopulmonary bypass surgery in a pati

Cardiopulmonary bypass surgery in a patient with paroxysmal nocturnal haemoglobinuria

✍ D. Dinesh; B. Baker; J. M. Carter 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Thrombophilic screening in patients with

Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study

✍ Francesco Dragoni; Anna Paola Iori; Patrizia Pignoloni; Chiara Minotti; Flavia C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Desmoplakin and KIF20B as target antigen

Desmoplakin and KIF20B as target antigens in patients with paroxysmal nocturnal haemoglobinuria

✍ Adnan Alahmad; Klaus-Dieter Preuss; Joachim Schenk; Wolfgang Füreder; Hubert Sch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

Effect of eculizumab on haemolysis-assoc

Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

✍ Anita Hill; Russell P. Rother; Xunde Wang; Sidney M. Morris; Jr; Kerry Quinn-Sen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

Successful liver transplantation for Bud

Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab

✍ Andrew L. Singer; Jamye E. Locke; Zoe A. Stewart; Bonnie E. Lonze; James P. Hami 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired hemolytic anemia caused by somatic mutations in the phosphatidylinositol glycan-complementation class A gene and the resulting absence of a key complement regulatory protein, CD59. Affected red blood cells in patients with PNH undergo int